• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1998 - 2000年西班牙南部间质性肺疾病的发病率:RENIA研究

Incidence of interstitial lung diseases in the south of Spain 1998-2000: the RENIA study.

作者信息

López-Campos José Luis, Rodríguez-Becerra Eulogio

机构信息

Medical-Surgical Unit of Respiratory Diseases, 'Virgen del Rocío' University Hospital, Seville, Spain.

出版信息

Eur J Epidemiol. 2004;19(2):155-61. doi: 10.1023/b:ejep.0000017660.18541.83.

DOI:10.1023/b:ejep.0000017660.18541.83
PMID:15074571
Abstract

UNLABELLED

This study aims to describe the distribution of interstitial lung diseases (ILD) in the South of Spain.

METHODS

A prospective multicentre population-based registry was established in nine provinces in the south of Spain with a population of 6,848,243 during a 3-year period (1998-2000). The number of participant physicians was 36 among 29 public hospitals. The number of diagnoses recorded was 66, divided in eight categories and coded according to ICD-9. A consensus document was elaborated for the classification of diseases and their diagnostic criteria. The number of cases declared was analysed each 3 months and communicated to each one of the participants.

RESULTS

There were 744 cases of them registered with an annual incidence of 3.62 cases/ 100,000. 40.1% of diagnoses were biopsy confirmed. Men had a slightly higher incidence (4.18 cases/ 100,000/year) than women (3.07 cases/100,000/year). The most frequent diseases found were: idiopathic interstitial pneumonias (38.58%), ILD associated to systemic diseases (20.97%), and Sarcoidosis (11.69%). According to province distribution, most of the cases were grouped in an area between the provinces of Seville and Cordoba, which comprised more than 50% of cases.

CONCLUSIONS

The study of the incidence of ILD depicts an intermediate situation from previous studies on the incidence and distribution of this group of diseases.

摘要

未标注

本研究旨在描述西班牙南部间质性肺疾病(ILD)的分布情况。

方法

在西班牙南部九个省份建立了一个前瞻性多中心基于人群的登记处,在三年期间(1998 - 2000年)覆盖人口6,848,243。29家公立医院中有36名参与医生。记录的诊断病例数为66例,分为八类并根据国际疾病分类第九版(ICD - 9)编码。制定了一份关于疾病分类及其诊断标准的共识文件。每三个月分析申报的病例数并传达给每位参与者。

结果

共登记了744例病例,年发病率为3.62例/10万。40.1%的诊断经活检证实。男性发病率(4.18例/10万/年)略高于女性(3.07例/10万/年)。最常见的疾病为:特发性间质性肺炎(38.58%)、与全身性疾病相关的ILD(20.97%)和结节病(11.69%)。根据省份分布,大多数病例集中在塞维利亚省和科尔多瓦省之间的一个区域,该区域病例占比超过50%。

结论

对ILD发病率的研究呈现出与以往关于这组疾病发病率和分布的研究相比处于中间水平的情况。

相似文献

1
Incidence of interstitial lung diseases in the south of Spain 1998-2000: the RENIA study.1998 - 2000年西班牙南部间质性肺疾病的发病率:RENIA研究
Eur J Epidemiol. 2004;19(2):155-61. doi: 10.1023/b:ejep.0000017660.18541.83.
2
Estimating the incidence of interstitial lung diseases in the Cree of Eeyou Istchee, northern Québec.估算魁北克北部伊尤伊斯切地区克里族间质性肺疾病的发病率。
PLoS One. 2017 Sep 8;12(9):e0184548. doi: 10.1371/journal.pone.0184548. eCollection 2017.
3
A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival.一项针对丹麦间质性肺疾病患者的队列研究:负担、严重程度、治疗与生存情况。
Dan Med J. 2015 Apr;62(4):B5069.
4
Report on the incidence of interstitial lung diseases in Spain.西班牙间质性肺疾病发病率报告。
Sarcoidosis Vasc Diffuse Lung Dis. 2004 Mar;21(1):64-70.
5
[Interstitial lung diseases among patients hospitalized in the Department of Respiratory Medicine in Radom District Hospital during the years 2000-2009].[2000年至2009年期间拉多姆地区医院呼吸内科住院患者的间质性肺疾病]
Pneumonol Alergol Pol. 2012;80(6):523-32.
6
The Italian register for diffuse infiltrative lung disorders (RIPID): a four-year report.
Sarcoidosis Vasc Diffuse Lung Dis. 2005 Dec;22 Suppl 1:S4-8.
7
A cohort study of interstitial lung diseases in central Denmark.丹麦中部间质性肺疾病的队列研究。
Respir Med. 2014 May;108(5):793-9. doi: 10.1016/j.rmed.2013.09.002. Epub 2013 Sep 20.
8
The epidemiology of interstitial lung diseases.间质性肺疾病的流行病学
Am J Respir Crit Care Med. 1994 Oct;150(4):967-72. doi: 10.1164/ajrccm.150.4.7921471.
9
Interstitial lung disease evaluation: detecting connective tissue disease.间质性肺疾病评估:检测结缔组织病
Respiration. 2015;90(3):177-84. doi: 10.1159/000440665. Epub 2015 Sep 8.
10
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.意大利癌症数据——2015年报告:意大利罕见癌症的负担
Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035.

引用本文的文献

1
Interstitial Lung Disease Epidemiology in the Past Three Decades: A Narrative Review.过去三十年间间质性肺疾病的流行病学:一篇综述
J Clin Med. 2024 Dec 2;13(23):7350. doi: 10.3390/jcm13237350.
2
Prevalence, incidence, and survival analysis of interstitial lung diseases in Hong Kong: a 16-year population-based cohort study.香港间质性肺疾病的患病率、发病率及生存分析:一项基于人群的16年队列研究。
Lancet Reg Health West Pac. 2023 Aug 10;42:100871. doi: 10.1016/j.lanwpc.2023.100871. eCollection 2024 Jan.
3
Exercise-Based Pulmonary Rehabilitation for Interstitial Lung Diseases: A Review of Components, Prescription, Efficacy, and Safety.

本文引用的文献

1
[Analysis of admissions for chronic obstructive pulmonary disease in Andalusia in 2000].[2000年安达卢西亚慢性阻塞性肺疾病入院情况分析]
Arch Bronconeumol. 2002 Oct;38(10):473-8. doi: 10.1016/s0300-2896(02)75268-x.
2
Interstitial lung diseases: an epidemiological overview.间质性肺疾病:流行病学概述
Eur Respir J Suppl. 2001 Sep;32:2s-16s.
3
Comparison of registries of interstitial lung diseases in three European countries.三个欧洲国家间质性肺疾病登记系统的比较。
基于运动的间质性肺疾病肺康复:组成部分、处方、疗效及安全性综述
Front Rehabil Sci. 2021 Nov 16;2:744102. doi: 10.3389/fresc.2021.744102. eCollection 2021.
4
Incidence, prevalence, and national burden of interstitial lung diseases in India: Estimates from two studies of 3089 subjects.印度间质性肺疾病的发病率、患病率和全国负担:两项 3089 例受试者研究的估计值。
PLoS One. 2022 Jul 21;17(7):e0271665. doi: 10.1371/journal.pone.0271665. eCollection 2022.
5
Interstitial lung disease incidence and mortality in the UK and the European Union: an observational study, 2001-2017.英国和欧盟间质性肺病的发病率与死亡率:一项2001 - 2017年的观察性研究
ERJ Open Res. 2022 Jul 11;8(3). doi: 10.1183/23120541.00058-2022. eCollection 2022 Jul.
6
Evaluation of Patients with Fibrotic Interstitial Lung Disease: Preliminary results from the Turk-UIP Study.纤维化间质性肺疾病患者的评估:土耳其特发性间质性肺炎(Turk-UIP)研究的初步结果。
Turk Thorac J. 2021 Mar;22(2):102-109. doi: 10.5152/TurkThoracJ.2021.20028. Epub 2021 Mar 1.
7
Interstitial lung disease in a veterans affairs regional network; a retrospective cohort study.退伍军人事务区域网络中的间质性肺疾病;一项回顾性队列研究。
PLoS One. 2021 Mar 18;16(3):e0247316. doi: 10.1371/journal.pone.0247316. eCollection 2021.
8
Australasian interstitial lung disease registry (AILDR): objectives, design and rationale of a bi-national prospective database.澳大拉西亚间质性肺病登记处(AILDR):一个跨国前瞻性数据库的目标、设计和原理。
BMC Pulm Med. 2020 Oct 2;20(1):257. doi: 10.1186/s12890-020-01297-2.
9
Type 2 macrophages and Th2 CD4+ cells in interstitial lung diseases (ILDs): an overview.间质性肺疾病(ILDs)中的2型巨噬细胞和Th2 CD4 +细胞:概述
Sarcoidosis Vasc Diffuse Lung Dis. 2018;35(2):98-108. doi: 10.36141/svdld.v35i2.6691. Epub 2018 Apr 28.
10
Demographic and clinical predictors of progression and mortality in connective tissue disease-associated interstitial lung disease: a retrospective cohort study.结缔组织病相关间质性肺疾病进展和死亡的人口统计学和临床预测因素:一项回顾性队列研究。
BMC Pulm Med. 2019 Oct 31;19(1):192. doi: 10.1186/s12890-019-0943-2.
Eur Respir J Suppl. 2001 Sep;32:114s-118s.
4
Pulmonary Langerhans'-cell histiocytosis.肺朗格汉斯细胞组织细胞增多症。
N Engl J Med. 2000 Jun 29;342(26):1969-78. doi: 10.1056/NEJM200006293422607.
5
American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS).美国胸科学会。特发性肺纤维化:诊断与治疗。国际共识声明。美国胸科学会(ATS)和欧洲呼吸学会(ERS)。
Am J Respir Crit Care Med. 2000 Feb;161(2 Pt 1):646-64. doi: 10.1164/ajrccm.161.2.ats3-00.
6
Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999.结节病声明。美国胸科学会(ATS)、欧洲呼吸学会(ERS)和结节病及其他肉芽肿性疾病世界协会(WASOG)的联合声明,1999年2月经ATS董事会和ERS执行委员会通过。
Am J Respir Crit Care Med. 1999 Aug;160(2):736-55. doi: 10.1164/ajrccm.160.2.ats4-99.
7
Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification.特发性肺纤维化:病理分类的临床相关性
Am J Respir Crit Care Med. 1998 Apr;157(4 Pt 1):1301-15. doi: 10.1164/ajrccm.157.4.9707039.
8
[Report by the Scientific Working Group for Therapy of Lung Diseases: German Fibrosis Register with initial results].[肺部疾病治疗科学工作组报告:德国纤维化登记册及初步结果]
Pneumologie. 1996 Dec;50(12):899-901.
9
World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects.世界医学协会赫尔辛基宣言。涉及人类受试者的生物医学研究中指导医师的建议。
JAMA. 1997 Mar 19;277(11):925-6.
10
Drugs that may injure the respiratory system.可能损害呼吸系统的药物。
Eur Respir J. 1997 Feb;10(2):265-79. doi: 10.1183/09031936.97.10020265.